Bokf, Na Astrazeneca PLC Transaction History

Bokf, Na

$5.65 Billion
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$66.81 - $80.83 $1.91 Million - $2.31 Million	28,637 Added 111.82%	54,246 $4.23 Million
Q1 2024 May 15, 2024	SELL	$61.03 - $69.57 $6.36 Million - $7.25 Million	-104,190 Reduced 80.27%	25,609 $1.74 Million
Q4 2023 Feb 14, 2024	SELL	$61.89 - $69.28 $419,737 - $469,856	-6,782 Reduced 4.97%	129,799 $8.74 Million
Q3 2023 Nov 14, 2023	SELL	$64.85 - $71.7 $296,948 - $328,314	-4,579 Reduced 3.24%	136,581 $9.25 Million
Q2 2023 Aug 21, 2023	SELL	$69.91 - $75.81 $127,865 - $138,656	-1,829 Reduced 1.28%	141,160 $10.1 Million
Q1 2023 May 11, 2023	SELL	$63.15 - $71.6 $700,396 - $794,115	-11,091 Reduced 7.2%	142,989 $9.92 Million
Q4 2022 Feb 13, 2023	SELL	$54.21 - $70.44 $7.1 Million - $9.22 Million	-130,890 Reduced 45.93%	154,080 $10.4 Million
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $306,084 - $783,684	-5,773 Reduced 1.99%	284,970 $15.6 Million
Q2 2022 Aug 11, 2022	BUY	$59.26 - $71.14 $998,590 - $1.2 Million	16,851 Added 6.15%	290,743 $19.2 Million
Q1 2022 May 13, 2022	BUY	$55.72 - $67.12 $6.42 Million - $7.73 Million	115,232 Added 72.63%	273,892 $18.2 Million
Q4 2021 Mar 11, 2022	BUY	$54.02 - $63.83 $178,644 - $211,085	3,307 Added 2.13%	158,660 $9.24 Million
Q3 2021 Nov 10, 2021	BUY	$55.56 - $60.79 $937,408 - $1.03 Million	16,872 Added 12.18%	155,353 $9.33 Million
Q1 2021 Apr 21, 2021	BUY	$47.16 - $54.44 $236,978 - $273,561	5,025 Added 3.77%	138,481 $6.89 Million
Q4 2020 Feb 12, 2021	SELL	$48.52 - $58.02 $1.39 Million - $1.67 Million	-28,726 Reduced 17.71%	133,456 $6.67 Million
Q3 2020 Oct 30, 2020	BUY	$53.07 - $61.1 $43,198 - $49,735	814 Added 0.5%	162,182 $8.89 Million
Q2 2020 Aug 12, 2020	BUY	$43.1 - $55.31 $319,069 - $409,459	7,403 Added 4.81%	161,368 $8.54 Million
Q1 2020 May 13, 2020	BUY	$37.79 - $51.33 $714,608 - $970,650	18,910 Added 14.0%	153,965 $6.88 Million
Q4 2019 Feb 12, 2020	SELL	$42.46 - $50.46 $583,103 - $692,967	-13,733 Reduced 9.23%	135,055 $6.73 Million
Q3 2019 Nov 13, 2019	BUY	$40.12 - $45.47 $887,935 - $1.01 Million	22,132 Added 17.47%	148,788 $6.63 Million
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $548,836 - $613,612	14,722 Added 13.15%	126,656 $5.23 Million
Q1 2019 May 15, 2019	SELL	$35.49 - $43.02 $192,888 - $233,813	-5,435 Reduced 4.63%	111,934 $4.53 Million
Q4 2018 Feb 13, 2019	BUY	$36.86 - $41.49 $36,380 - $40,950	987 Added 0.85%	117,369 $4.46 Million
Q3 2018 Nov 13, 2018	SELL	$34.76 - $39.72 $48,559 - $55,488	-1,397 Reduced 1.19%	116,382 $4.61 Million
Q2 2018 Aug 13, 2018	SELL	$34.55 - $37.05 $302,208 - $324,076	-8,747 Reduced 6.91%	117,779 $4.14 Million
Q1 2018 May 14, 2018	BUY	$32.97 - $36.63 $939,480 - $1.04 Million	28,495 Added 29.07%	126,526 $4.43 Million
Q4 2017 Feb 14, 2018	BUY	$32.09 - $34.78 $571,522 - $619,431	17,810 Added 22.2%	98,031 $3.4 Million
Q3 2017 Nov 14, 2017	BUY	$28.96 - $34.0 $550,153 - $645,898	18,997 Added 31.03%	80,221 $2.72 Million
Q2 2017 Aug 14, 2017	BUY	N/A	61,224	61,224 $2.09 Million

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

Price T Rowe Associates Inc Baltimore, MD

62.9M
Shares

$4.05 Billion
0.56% of portfolio
Primecap Management CO Pasadena, CA

42M
Shares

$2.71 Billion
2.45% of portfolio
Wellington Management Group LLP Boston, MA

37.2M
Shares

$2.4 Billion
0.52% of portfolio
Capital International Investors Los Angeles, CA

36.8M
Shares

$2.37 Billion
0.57% of portfolio
Franklin Resources Inc San Mateo, CA

19.1M
Shares

$1.23 Billion
0.45% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

News

Stay updated on Bokf, Na with notifications on news.

Account